Efficacy and Safety of Bimagrumab in Sporadic Inclusion Body Myositis: Long-term Extension of RESILIENT

OBJECTIVE: To assess long-term (2 years) effects of bimagrumab in participants with sporadic inclusion body myositis (sIBM). METHODS: Participants (aged 36–85 years) who completed the core study (RESILIENT [Efficacy and Safety of Bimagrumab/BYM338 at 52 Weeks on Physical Function, Muscle Strength, M...

Szczegółowa specyfikacja

Zapisane w:
Opis bibliograficzny
Wydane w:Neurology
Główni autorzy: Amato, Anthony A., Hanna, Michael G., Machado, Pedro M., Badrising, Umesh A., Chinoy, Hector, Benveniste, Olivier, Karanam, Ananda Krishna, Wu, Min, Tankó, László B., Schubert-Tennigkeit, Agnes Annette, Papanicolaou, Dimitris A., Lloyd, Thomas E., Needham, Merrilee, Liang, Christina, Reardon, Katrina A., de Visser, Marianne, Ascherman, Dana P., Barohn, Richard J., Dimachkie, Mazen M., Miller, James A.L., Kissel, John T., Oskarsson, Björn, Joyce, Nanette C., Van den Bergh, Peter, Baets, Jonathan, De Bleecker, Jan L., Karam, Chafic, David, William S., Mirabella, Massimiliano, Nations, Sharon P., Jung, Hans H., Pegoraro, Elena, Maggi, Lorenzo, Rodolico, Carmelo, Filosto, Massimiliano, Shaibani, Aziz I., Sivakumar, Kumaraswamy, Goyal, Namita A., Mori-Yoshimura, Madoka, Yamashita, Satoshi, Suzuki, Naoki, Aoki, Masashi, Katsuno, Masahisa, Morihata, Hirokazu, Murata, Kenya, Nodera, Hiroyuki, Nishino, Ichizo, Romano, Carla D., Williams, Valerie S.L., Vissing, John, Zhang Auberson, Lixin
Format: Artigo
Język:Inglês
Wydane: Lippincott Williams & Wilkins 2021
Hasła przedmiotowe:
Article
Dostęp online:https://ncbi.nlm.nih.gov/pmc/articles/PMC8032371/
https://ncbi.nlm.nih.gov/pubmed/33597289
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0000000000011626
Etykiety: Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!

Podobne zapisy